Indication: Neuroblastoma
LEAHRN (Late Effects After High-Risk Neuroblastoma) Study
Sub-indication: Neuroblastoma
Study Type: Specimen Study
Principal Investigator: Kerry K. McGowan, M.D.Norton Children's Cancer Institute, affiliated with the UofL School of Medicine
Sponsor: Sponsor: Children's Oncology Group (COG)
Learn more at ClinicalTrials.gov
Email for more information: NCRI-Cancer@NortonHealthcare.org
